HB-954 AS A TARGET FOR MODULATING ANGIOGENESIS

Details for Australian Patent Application No. 2003267026 (hide)

Owner NOVARTIS AG

Inventors SERDIKOFF, Cynthia; DIXON, Katharine, H.; LIAU, Gene

Pub. Number AU-A-2003267026

PCT Number PCT/EP03/09619

PCT Pub. Number WO2004/024763

Priority 60/407,063 30.08.02 US

Filing date 29 August 2003

Wipo publication date 30 April 2004

International Classifications

C07K 014/705 Peptides having more than 20 amino acids

A61K 038/17 Medicinal preparations containing peptides - from animals

Event Publications

8 January 2004 Complete Application Filed

  Priority application(s): 60/407,063 30.08.02 US

20 May 2004 Application Open to Public Inspection

  Published as AU-A-2003267026

16 June 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003267027-TWO-DIMENSIONAL DEPICTION OF COMPONENTS OF A FILM EXTRUSION SYSTEM ON AN OUTPUT DEVICE

2003267025-METHOD FOR GENERATING DENDRITIC CELLS PRECURSORS IN VITRO